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Abstract
The rise of extended-spectrum beta-lactamase (ESBL)-producing
Escherichia coli in food-producing animals is a growing concern for
public health. We investigated ESBL producers isolated from
broiler chickens in Brazil and characterized 19 CTX-M-2-produc-
ing E. coli. The ISCR1 was detected upstream of the chromo-
some-located gene blaCTX-M-2, associated with sul-1 type integron
structure. CTX-M-2-producing E. coli exhibited different PFGE-
types and phylogenetic groups, showing a non-clonal dissemina-
tion. The sequence types found (ST93, ST155 and ST2309) have
been associated with humans and animals worldwide. Herein, we
report the chromosomal location of blaCTX-M-2 on E. coli,
highlighting the risks of multidrug-resistant bacteria in food-
producing animals.
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Prophylactic antibiotics are used in poultry production to
prevent gastrointestinal infections and thus improve the
performance of commercial broilers. The prevalence of
extended-spectrum beta-lactamase (ESBL)-producing Escheri-
chia coli colonizing the intestinal tract of healthy food-producing
animals, including poultry, has increased worldwide [1]. There is
a risk of transmission of poultry-associated ESBL-producing
Enterobacteriaceae to humans [2]. Many genetic platforms
associated with mobilization and support of blaCTX-M were
identiﬁed, especially ISEcp1 and ISCR1elements, where the latter
is particularly important for blaCTX-M-2 dissemination [3]. In this
study, we report different clones of CTX-M-2-producing E. coli,
with chromosomal-located genes.
From 2011 to 2012, 200 cloacal swabs were harvested from
healthy broilers in two poultry farms from S~ao Paulo State,
Brazil. Swabs were seeded onto MacConkey agar plates
containing 1 mg/L of cefotaxime and also onto plates
containing 1 mg/L of ceftazidime, and incubated for 24 h/
37°C. From each sample, one colony per morphotype was
selected and identiﬁed by the API 20E test (BioMerieux, Marcy
l’Etoile, France). ESBL-producing E. coli were screened by
double disk synergism using cefotaxime and ceftazidime plus
amoxicillin/clavulanic acid, which showed 19 (9.5%) isolates
with the ESBL phenotype. The blaTEM, blaSHV, blaCTX and
blaOXA genes were searched by PCR and the sequencing
conﬁrmed the presence of the blaCTX-M-2 gene in these isolates
using primers described previously [4]. The genetic environ-
ment of blaCTX-M-2 was identiﬁed following previously
described methods [5]. The ISCR1 was found upstream of
the blaCTX-M-2 and the resistance gene was associated with
sul-1 type integron structure. The susceptibility test was
performed by the agar disk diffusion method using beta-
lactams, amoxillin/clavulanic acid, piperacillin/tazobactam,
cefotaxime, ceftazidime, cefepime, cefoxitin, aztreonam and
ertapenem, and non-beta-lactams, nalidixic acid (NAL), cipro-
ﬂoxacin (CIP), levoﬂoxacin (LVX), tetracycline (TET), genta-
micin (GEN), trimethoprim-sulphamethoxazole (SXT) and
chloramphenicol (CHL). The results were evaluated according
to the Clinical Laboratory Standards Institute recommenda-
tions [6]. Most isolates showed resistance to all beta-lactams
tested, with 100% susceptibility to ertapenem. All isolates
showed resistance to the non-beta-lactam antibiotics CIP,
LVX, NAL and TET, 73.7% (14/19) were resistant to GEN and
SXT and 31.5% (6/19) were resistant to CHL (Fig. 1).
Plasmid-mediated resistance to quinolone antibiotics asso-
ciated with the CTX-M-2-producing E. coli was checked by
PCR based on the presence of qnrA, qnrB, qnrS and acc(6′)-Ib-cr
genes, as described elsewhere [7]. Two isolates presented
qnrB19 gene (Fig. 1).
The phylogenetic group characterization, following the
methods previously described [8], identiﬁed 68.5% (13/19)
from phylogenetic group A, 26.3% (5/19) of isolates from
group D and 5.2% (1/19) from group B1 (Fig. 1). Moreover,
genomic relationship was analysed by pulsed-ﬁeld gel
electrophoresis (PFGE) using the CHEF DRIII PFGE System
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(Bio-Rad, Hercules, CA, USA) after enzymatic digestion with
XbaI. Results were evaluated using the Bionumerics Software
version 5.01 (Applied Maths, Austin, TX, USA) and the isolates
were considered from the same PFGE-type when the genomic
similarity was greater than 85% (Fig. 1). Therefore, according
to the criteria used, the 19 CTX-M-2-producing E. coli isolates
belong to six PFGE-types. Four different PFGE-types (A, B, C
and D) were found among the six isolates from farm 1. In farm
2, two PFGE-types (E and F) were found among the 13 isolates.
The relatedness between PFGE-types from both farms was at
most 75% (Fig. 1). The MLST, carried out according to the
‘Achtman scheme’ (http://mlst.ucc.ie/mlst/dbs/Ecoli), showed
three sequence types (STs). ST2309 has not been assigned to
any clonal complex (CC) to date; furthermore, it was only
described in broilers. ST93 was ascribed to CC168 and ST155
to CC155 (Fig. 1). ST93 was dominant among isolates and,
together with ST155, has been associated with humans and
animals worldwide [9–11].
Plasmids were searched and characterized following the
PCR-based replicon typing method [12]. All 19 ESBL-producing
isolates presented replicons F, B/O, K, I1 and FIB. PFGE after
S1-nuclease digestion, Southern blot and hybridization with
speciﬁc probes were performed to search for the blaCTX-M-2
gene in plasmids; however it was not found. The method was
repeated after I-Ceu-I-PFGE using probes for the E. coli 16S
rRNA gene and for blaCTX-M-2 to evaluate chromosomal
localization. These probes hybridized in the same position,
conﬁrming the insertion of blaCTX-M-2 in the chromosome
(Fig. 2) of all 19 ESBL isolates. Moreover, to check the
possibility of chromosomal integration of the plasmids along
with the resistance gene, probes for each replicon (F, B/O, K,
I1 and FIB) were used in the same membrane. Nevertheless, no
plasmids were integrated into the chromosome.
All isolates were considered multidrug-resistant (non-
susceptible) to at least one agent in three or more antimicro-
bial categories [13], showing an important reservoir of
resistance genes in these food-producing animals. The
blaCTX-M-2 gene is the most prevalent ESBL-encoding gene in
human E. coli isolates in Brazil [14] and is frequently reported
in animals and environmental sources [1]. Although blaCTX-M
genes are usually harboured in plasmids, the chromosomal
insertion of these genes was found in E. coli [15–17]. Herein,
we showed the chromosomal blaCTX-M-2 in diverse E. coli
isolates. The ISCR1 found in these CTX-M-2-producing E. coli
isolates has been associated with the mobilization of
CTX-M-encoding genes in both Gram-negative and Gram-po-
sitive pathogens [18].
The quinolone resistance detected in all E. coli isolates might
be related to chromosomal mutations in quinolone-resis-
tance-determining regions or associated with other resistance
mechanisms (e.g. porin deﬁciencies, over-expressing of efﬂux).
Nevertheless, the presence of the qnr genemay represent risk of
dissemination of co-resistance in bacteria [19].
Our ﬁndings suggest that the continuous use of sub-inhib-
itory antibiotic concentrations, in the poultry environment,
may promote the genetic recombination in E. coli, as shown
elsewhere [20]. This hypothesis is supported by different
PFGE-types and phylogenetic groups detected, pointing to
FIG. 1. Dendrogram of genomic similarity obtained by XbaI-PFGE of 19 ESBL-producing Escherichia coli isolates from broiler chickens. NAL,
nalidixic acid; CIP, ciproﬂoxacin; LVX, levoﬂoxacin; TET, tetracycline; GEN, gentamicin; SXT, trimethoprim/sulphamethoxazole; CHL, chloram-
phenicol.
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non-clonal dissemination of chromosome-encoding CTX-M-2
in E. coli. The stability of the chromosomal blaCTX-M-2 in
bacterial strains is still to be elucidated.
In summary, this study identiﬁed 19 CTX-M-2-producing
E. coli isolates in Brazil from commercial broilers for human
consumption, and characterized the insertion of the blaCTX-M-2
gene into the bacterial chromosome.
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